Skip to main content

. 1987 Sep 26;295(6601):752–753. doi: 10.1136/bmj.295.6601.752

Near fatal drug interactions with methotrexate given for psoriasis.

H W Ng ¹, A W Macfarlane ¹, R M Graham ¹, J L Verbov ¹

PMCID: PMC1247775 PMID: 3119023

Images in this article

p752-a
on p.752

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Daly H. M., Scott G. L., Boyle J., Roberts C. J. Methotrexate toxicity precipitated by azapropazone. Br J Dermatol. 1986 Jun;114(6):733–735. doi: 10.1111/j.1365-2133.1986.tb04883.x. [DOI] [PubMed] [Google Scholar]
Dodd H. J., Kirby J. D., Munro D. D. Megaloblastic anaemia in psoriatic patients treated with methotrexate. Br J Dermatol. 1985 May;112(5):630–631. doi: 10.1111/j.1365-2133.1985.tb15279.x. [DOI] [PubMed] [Google Scholar]
Hendel J., Nyfors A. Impact of methotrexate therapy on the folate status of psoriatic patients. Clin Exp Dermatol. 1985 Jan;10(1):30–35. doi: 10.1111/j.1365-2230.1985.tb02548.x. [DOI] [PubMed] [Google Scholar]
Lawrence C. M., Dahl M. G. Two patterns of skin ulceration induced by methotrexate in patients with psoriasis. J Am Acad Dermatol. 1984 Dec;11(6):1059–1065. doi: 10.1016/s0190-9622(84)70259-3. [DOI] [PubMed] [Google Scholar]
McDonald C. J. Cytotoxic agents for use in dermatology. I. J Am Acad Dermatol. 1985 May;12(5 Pt 1):753–775. doi: 10.1016/s0190-9622(85)70097-7. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES